Ocular Therapeutix (OCUL) Treasury Shares (2013 - 2014)

Ocular Therapeutix has reported Treasury Shares for 6 years, with the latest figure at $4.4 million in Q4 2025.

• Treasury Shares for Q4 2025 came in at $4.4 million, up 28.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.4 million (up 28.61% YoY), and the FY2025 annual result was $4.4 million, up 28.61% from the prior year.
• Treasury Shares grew to $4.4 million in Q4 2025, from $3.4 million in the prior quarter.
• Over five years, Treasury Shares peaked at $4.4 million in Q4 2025 and troughed at $1.1 million in Q4 2022.
• A 4-year average of $2.6 million and a median of $2.5 million in 2023 frame the typical range for Treasury Shares.
• The widest annual swing landed in 2024, when Treasury Shares surged 108.29%; it then grew 28.61% in 2025.
• A 4-year view of Treasury Shares shows it stood at $1.1 million in 2022, then surged by 48.93% to $1.6 million in 2023, then surged by 108.29% to $3.4 million in 2024, then gained by 28.61% to $4.4 million in 2025.
• Per Business Quant data, the three most recent Treasury Shares figures were $4.4 million in Q4 2025, $3.4 million in Q4 2024, and $1.6 million in Q4 2023.